BOULDER, CO / ACCESSWIRE / November 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 second quarter that ended September 30, 2024. The Company posted quarterly product net revenue of $1.65 million and service net revenue of $101 thousand, or total net revenue of $1.75 million for a quarterly net loss of $170 thousand, or $(0.01) per diluted share.
BOULDER, CO / ACCESSWIRE / August 21, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray energy burns in minimally invasive surgery, today announced that Encision has signed a Master Services Agreement ("Agreement") with Vicarious Surgical Inc. ("Vicarious"). The Agreement commenced July 8, 2024 and will continue thereafter until terminated by certain actions of either party.
BOULDER, CO / ACCESSWIRE / August 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2025 first quarter that ended June 30, 2024. The Company posted quarterly product net revenue of $1.59 million and service net revenue of $39 thousand, or total net revenue of $1.63 million for a quarterly net income of $22 thousand, or $0.00 per diluted share.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Robert H. Fries CEO | OTC PINK Exchange | 29254Q104 CUSIP |
| US Country | 23 Employees | - Last Dividend | - Last Split | 25 Jun 1996 IPO Date |
Encision Inc. is a distinguished player in the medical device sector, specializing in the design, development, manufacture, and marketing of patented surgical instruments within the United States. The core of Encision's innovation revolves around its proprietary active electrode monitoring (AEM) technology, which significantly enhances patient safety and outcomes in laparoscopic surgeries. Established in 1991 and headquartered in Boulder, Colorado, Encision has positioned itself as a vital contributor to the field of minimally invasive surgery through its commitment to innovation, safety, and the continuous improvement of surgical outcomes.
Encision's portfolio is particularly geared towards enhancing laparoscopic surgical procedures. The company's offerings can be categorized into specific product lines, each designed with the aim of improving surgical efficiency, safety, and patient outcomes. The detailed overview of their products and services includes:
These products are made available to the healthcare sector through a strategic network of direct and independent sales representatives, ensuring that Encision's innovative solutions are accessible to hospitals and surgical centers across the nation.